BRIGHT MINDS BIOSCIENCES INC. (DRUG)
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Bright Minds Biosciences Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 9, 2026 | 23.00 | 24.44 | 22.61 | 24.11 | 93,650 |
| Nov 6, 2026 | 21.29 | 23.39 | 20.70 | 23.00 | 197,379 |
| Nov 5, 2026 | 18.75 | 20.86 | 17.40 | 20.70 | 438,878 |
| Nov 4, 2026 | 22.10 | 22.48 | 18.10 | 18.96 | 500,359 |
| Nov 3, 2026 | 25.07 | 26.69 | 21.09 | 21.55 | 995,459 |
| Nov 2, 2026 | 29.20 | 29.94 | 18.90 | 26.20 | 1,827,134 |
| Oct 30, 2026 | 56.90 | 57.00 | 54.96 | 54.98 | 95,820 |
| Oct 29, 2026 | 56.35 | 57.79 | 55.84 | 56.69 | 67,541 |
| Oct 28, 2026 | 54.25 | 56.13 | 53.65 | 55.32 | 71,096 |
| Oct 27, 2026 | 51.17 | 54.83 | 49.89 | 54.02 | 59,413 |
| Oct 26, 2026 | 52.72 | 53.46 | 50.29 | 51.09 | 89,060 |
| Oct 23, 2026 | 51.77 | 52.65 | 51.00 | 52.48 | 59,192 |
| Oct 22, 2026 | 50.44 | 53.10 | 49.92 | 52.69 | 221,305 |
| Oct 21, 2026 | 55.34 | 59.71 | 49.80 | 50.44 | 156,372 |
| Oct 20, 2026 | 54.00 | 57.49 | 54.00 | 55.20 | 94,698 |
| Oct 19, 2026 | 53.07 | 54.27 | 49.87 | 53.82 | 156,325 |
| Oct 16, 2026 | 54.15 | 54.15 | 51.30 | 51.30 | 56,035 |
| Oct 15, 2026 | 51.80 | 55.75 | 51.24 | 54.21 | 121,463 |
| Oct 14, 2026 | 50.52 | 52.96 | 49.06 | 50.71 | 199,356 |
| Oct 13, 2026 | 54.01 | 54.35 | 50.99 | 51.36 | 246,572 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Cormorant Asset Management, LP | -- | Sale | 109.3K | $9.79M | Apr 28, 2026 |
| Cormorant Asset Management, LP | -- | Purchase | 184.3K | $4.00M | Nov 4, 2024 |
| Cormorant Asset Management, LP | -- | Purchase | 39.7K | $922.6K | Oct 16, 2024 |
| Cormorant Asset Management, LP | -- | Purchase | 7.2K | $171.8K | Oct 16, 2024 |
| Cormorant Asset Management, LP | -- | Purchase | 3.1K | $78.4K | Oct 16, 2024 |
| Cormorant Asset Management, LP | -- | Purchase | 2.7K | $25.0K | Oct 15, 2024 |
| Name | Shares | % | Source |
|---|---|---|---|
Ian McDonald · may incl. warrants· filed Jul 2026 | 1.4M | 14.2% | 13D |
Jupiter Topco LLC | 1.3M | 13.7% | 13F |
JANUS HENDERSON GROUP PLC · may incl. warrants· filed May 2026 | 1.3M | 13.0% | 13G |
Cormorant Asset Management, LP · also on 13F· joint filing· may incl. warrants· filed Apr 2026 | 950.0K | 9.6% | 13G |
Cormorant Asset Management, LP | 900.0K | 9.1% | 13F |
BlackRock, Inc. | 686.2K | 7.0% | 13F |
Vivo Capital, LLC | 557.2K | 5.6% | 13F |
Vestal Point Capital, LP | 545.0K | 5.5% | 13F |
Vivo Opportunity Fund Holdings, L.P. · also on 13F· joint filing· may incl. warrants· filed May 2026 | 504.6K | 5.1% | 13G |
BRAIDWELL LP | 483.8K | 4.9% | 13F |
Insiders
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases.
Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry.
The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin.
The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
based on 9.86M shares outstanding
CA30d Avg
289.40K
60d Avg
207.87K
90d Avg
174.49K